Анестезия и педиатрия - Джордж А.Г.
ISBN 5-225-03821-2
Скачать (прямая ссылка):
777. Civetta JM, Hudson-Civetta J, Ball S: Decreasing catheter-related infection and hospital costs by continuous
Suality improvement. Crit Care Med 24:|660, 1996 >’Leary M, Bihari D: Central venous catheters — time for a change? If you put them in property you don’t need to change them routinely. BMJ 316:1918, 1998
779. Badley AD, Steckelbeig JM, Wollan PC, et al; Infections rates of central venous pressure catheters: comparison between newly placed catheters and those that heve been changed. Mayo Clin Proc 71:838, 1996
780. Anonymous: Guidelines for prevention of intravascular device-related infections. Part [I. Recommendations for the prevention of nosocomial intravascular device-related iofections. Hospital Infection Centro) Practices Advisory Committee (review]. Am J Infect Control 24:277, 1996
781. Cobb DK, High KP, Sawyer RG, et al: A controlled trial of scheduled replacement of central venous and pulmo-nary-artery catheters. N Engl J Med 327:1062, 1992
782. Eyer S, Brum mitt C, Crossley K, et al: Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med 18:1073,
1990
783. Maki DG, Stolz SM, Wheeter S, et al: Prevention of central venous caiheter-related bloodstream infection by use of an antisepticimpregnated cathether. A randomized, controlled trial. Ann Intern Med 127:257, 1997
784. Wenzel RP, Edmond MB: The evolving technology of venous access. N Engl J Med 340:48, (999
785. Darouiche RO, Raad 11, Heard SO, et al: A comparison of two antimicrobial-impregnated central venous catheters. Catheter Stndy Group. N Engl J Med 340:1, 1999
706. Raad I, Darouiche R, Dupuis J, et al: Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Cetbeter Study Group. Ann Intern Med 127:267, 1997
787. Kollef MH: The prevention of ventilator-associated pneumonia. N Engl J Med 340:627, 1999
788. Craven DE, Steger KA: Ventilator-associated bacterial pneumonia: challenges in diagnosis, treatment, and prevention. New Horiz 6(Suppl).S30, 1990
789. Mariscalco MM: Infection and tbe host response, p. 9|7. In Fuhrman BP, Zimmerman JJ (eds): Pediatric critical Care. Mosby Year Book, St. Louis, (992
790. Karakusis PH: Considerations in the tbe гару of septic shock. Med Clin North Am 70:933, 1986
791. Andersoi) MR, Blunter JL Advances in the therapy for sepsis in children. Pediatr Clin North Am 44:179, 1997
792. Careillo JA, Connion RE: Septic thock. Crit care Clin 13:553, 1997
793. Sullivan JS, Kilpatrick L, Costarino AT Jr, et al: Correlation of plasma cytokine elevations with mortality rate in children with sepsis. J Pedialr 120:510, 1992
794. BJesenfetd-Om I, Wolpe S, Garcia-Bustos JF, et al: Production of interieukin-1 but not tumor necrosis (actor by human monocytes stimulated with pneumococcal cell surface components. Infect Iminun 57:1890, (989
795. Sriskandan S, Cohen J: Gram-positive sepsis. Meche-nisms and differences from gram-negative sepsis (review). Infect Dis Clin North Am 13:397, 1999
796. Blanco A, Solis G, Arranz E, et al: Sarum levels of CDI4 in neonatal sepsis by Gram-positive and Gram-negative bacteria. Acta Paediatr 85:728, 1996
797. Ziramerman JJ, Dietrich KA: Current perspectives on septic shock. Pediatr Clin North Am 34:131, 1987
798. Jacobs ER, Bone RC: Clioical indicators in sepsis and septic adult respiratory distress syndrome. Med Clin North Am 70:921, 1986
1166 Анестезия в педиатрии
799. McCabe WR, Treadwell TL, De Maria A Jr: Pathophysiology of bacteremia. Am J Med 78:7, I983
800. Herdegcn JJ, Casey LC: The role of tumor necrosis factor in infections: pathophysiology and clinical implications. Infec Med 10:27, 1993
801. Michie HR, Manogue KR, Spriggs OR, et al: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481, 1988
802. Dinarello CA, Wolff SM: The role of interleukin-1 in disease. N Engl J Med 328:106, 1993
803. Girardin E, Roux-Lomberd P,GrauGE,etal: Imbelance between tumour necrosis factor-а and soluble TNF receptor concentrations in severe meningococcaemia. The JS stndy group. Immunology 76:20, 1992
804. Green man RL, Schein RM, Martin MA, et al: A controlled clinical trial of ES murine monoclonal IgM amibody to endotoxin in tbe treatment of gram-negative sepsis. JAMA 266:1097, 1991
805. Bone RC: Monoclonal antibodies to endotoxin: new allies against sepsis? JAMA 266:1125, 1991
806. Warren HS, Dunner RL, Munford RS: Anti-endotoxin monoclonal antibodies. N Engl J Med 326:1153, 1992
807. Wenzel RP: Anti-endotoxin monoclonal antibodies — a second look. N Engl J Med 326 H5I, 1992
808. Nasraway SA: Sepsis research: we must change course. Crit Care Med 27:427, 1999
809. Parker MM: Pathophysiology of cardiovascular dysfunction in septic shock |review). New Horiz 6:130, 1998
810. Pollack MM, Fields Al, Ruttimann UE: Sequential cardiopulmonary variables of infants and children in septic shock. Crit Care Med 12:554, 1984
